Embark Early Education Ltd

Embark Early Education has a market capitalization of $81.46 million and a price-to-earnings ratio of 7.61, indicating a relatively low valuation compared to earnings. The company's price-to-book ratio is 0.76, suggesting that the market value is below the book value of its assets. The enterprise value to EBITDA ratio is 7.85, and the enterprise value to revenue ratio is 1.96, both of which are within the range of typical valuations for the personal services industry. In terms of profitability, the company has a return on equity of 10.04% and a return on assets of 4.39%. These figures indicate that the company is generating a reasonable return on its equity but a lower return on its total assets. The operating margin is 24.92%, and the net profit margin is 10.21%, which are both in line with the industry's median performance. The company's revenue is concentrated in Australia, with the majority of its centers located in Queensland and Victoria. This geographic concentration may expose the company to regional economic fluctuations. The company operates under multiple brands, including Roseberry House, Brighthouse, and Cubby care, which may help in diversifying its customer base and brand recognition. Looking at the growth trajectory, the company's revenue has shown a positive trend, with a revenue of $104.91 million in the latest period. The company's capital expenditure is negative, indicating that it is generating more cash from operations than it is spending on capital investments. This could suggest a period of maintenance rather than expansion. The company faces a medium liquidity risk, as indicated by its current ratio of 1.1, which is slightly below the ideal ratio of 1.5. The debt-to-equity ratio is 1.16, indicating a moderate level of leverage. The risk assessment also notes that the company has a negative net cash position after subtracting total debt, which could be a concern for liquidity. Recent events and filings show that the company has a mean price target of $1.01 from analysts, with a median price target of $1.01. The mean recommendation is 1.50, indicating a generally positive outlook from analysts. The company has one strong-buy and one buy recommendation, with no hold recommendations, suggesting a favorable sentiment among analysts.